title: Cutaneous pigmentation after daunorubicin chemotherapy.
authors.affiliation: Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, TX 78234-6200.
authors.forename: L L
authors.initials: LL
authors.lastname: Anderson
authors.forename: D E
authors.initials: DE
authors.lastname: Thomas
authors.forename: T G
authors.initials: TG
authors.lastname: Berger
authors.forename: S J
authors.initials: SJ
authors.lastname: Vukelja
mesh_terms: D000328:Adult; D003630:Daunorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D009260:Nail Diseases / Q000139:chemically induced*; D010859:Pigmentation Disorders / Q000139:chemically induced*
chemical_list: D003630:Daunorubicin